Design Therapeutics, Inc. DSGN
9.45 USD -0.02 (-0.21%)
As ofNov 19, 2026, 1:35 PM EST
9.22 Day range 9.72
7.81 52-week range 17.25
- YTD
- +0.75%
- 1 year
- +28.75%
News
benzinga.com RBC Capital Maintains Outperform on Design Therapeutics, Lowers Price Target to $19 RBC Capital analyst Leonid Timashev maintains Design Therapeutics (NASDAQ:DSGN) with a Outperform and lowers the price target from $20 to $19.
benzinga.com Design Therapeutics Q3 EPS $(0.32) Beats $(0.35) Estimate Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.35) by 8.57 percent. This is a 6.67 percent decrease over losses of…
